RizLab Health
Bringing blood analysis to patients' fingertips
RizLab Health operates in computational bio based in United States, founded in 2018.
Profile
RizLab Health is addressing the pandemic of antimicrobial resistance and helping clinicians by pinpointing the source of infection (and thus preventing inappropriate antibiotic prescriptions) with their point-of-care device, the CytoTracker. The CytoTracker differentiates bacterial from viral infection profiles within minutes using only a single drop of blood. A 200-person clinical study demonstrated the CytoTracker beats the specificity of current testing methods, making it the most affordable, portable, and accurate blood analyzer.
Its activity falls under computational bio; the profile below is assembled from public directory data.
The business is associated with United States.
Its current recorded stage is SOSV portfolio company.
Its team size is recorded as 2-10 employees.
It has disclosed roughly $2.2M in funding.
| Sector | Computational Bio |
|---|---|
| Country | United States |
| Founded | 2018 |
| Employees | 2-10 |
| Stage | SOSV portfolio company |
| Total funding | $2,200,000 |
Website: rizlabhealth.com
Browse related
Create a free account